Inventor

SARGES REINHARD

US47 patents

Patents

47 patents

US5998463ADec 7, 1999

4-arylsulfonyl-3,4-dihydro-2(1H)-quinoxalinone-1-alkanoic acids, esters, and salts

PFIZER8 citations74

US4623725ANov 18, 1986

[1,2,4]Triazolo[4,3-a]quinoxaline-4-amine derivatives

PFIZER10 citations74

US4623728ANov 18, 1986

Intermediates for 1,3-disubstituted piperidine compounds as neuroleptic agents

PFIZER12 citations74

US4593037AJun 3, 1986

1,3-disubstituted piperidine compounds as neuroleptic agents

PFIZER9 citations74

US4547501AOct 15, 1985

Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents

PFIZER9 citations74

US4495187AJan 22, 1985

Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents

PFIZER13 citations74

US4348526ASep 7, 1982

Intermediates in the preparation of chiral hydantoins

PFIZER11 citations74

US4286098AAug 25, 1981

Process for the preparation of chiral hydantoins

PFIZER15 citations74

US4235911ANov 25, 1980

Hydantoin derivatives

PFIZER11 citations74

US4209630AJun 24, 1980

Hydantoin derivatives as therapeutic agents

PFIZER11 citations74

US4209527AJun 24, 1980

Benzimidazolone derivatives

PFIZER11 citations74

US4977178ADec 11, 1990

Method of treating anxiety and depression with 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents

PFIZER11 citations73

US4960785AOct 2, 1990

Indolinone derivatives

PFIZER11 citations73

US4181728AJan 1, 1980

Spiro-polycyclicimidazolidinedione derivatives

PFIZER16 citations73

US4147797AApr 3, 1979

Spiro-furanohydantoin derivatives

PFIZER12 citations70

US4474967AOct 2, 1984

8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione

PFIZER3 citations63

US4419521ADec 6, 1983

6-Halo-4-chromanamines useful as intermediates to make chiral hydantoins

PFIZER2 citations63

US4273775AJun 16, 1981

Hydantoin derivatives, anti-diabetic compositions thereof, and method of use thereof

PFIZER3 citations63

US4258054AMar 24, 1981

Hydantoin derivatives as therapeutic agents

PFIZER6 citations63

US4210756AJul 1, 1980

Tetrahydroquinoline hydantoins for chronic diabetic complications

PFIZER4 citations63

US4177282ADec 4, 1979

Hydantoin therapeutic agents

PFIZER5 citations63

US3961065AJun 1, 1976

Benzenesulfonylurea derivatives

PFIZER2 citations63

US4879391ANov 7, 1989

1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents

PFIZER5 citations62

US4861880AAug 29, 1989

1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents

PFIZER3 citations62

US4476307AOct 9, 1984

Heteroylidene indolone compounds

PFIZER6 citations62

US4471124ASep 11, 1984

Spiro-imide derivatives

PFIZER3 citations62

US4442114AApr 10, 1984

Imide derivatives

PFIZER4 citations62

US4283409AAug 11, 1981

Imidazolone derivatives

PFIZER3 citations62

US5362743ANov 8, 1994

Aminoquinoline derivatives

PFIZER5 citations61

US3987172AOct 19, 1976

Piperidinesulfonylurea derivatives

PFIZER3 citations60

US3944524AMar 16, 1976

4-Substituted-1-piperidinesulfonamides

PFIZER3 citations60

US3961067AJun 1, 1976

Composition comprising a benzenesulfonylurea hypoglycemic agent and method of treatment

PFIZER0 citations50

SARGES REINHARD

Patents

Glycogen phosphorylase inhibitors

Hydantoin therapeutic agents

Hydantoin derivatives as therapeutic agents

Azolidinedione derivatives

Hydantoin derivatives as therapeutic agents

Thienohydantoin derivatives

Pharmaceutical preparations containing coumarin carboxylic acid derivatives

Combination therapy for Parkinson&#39;s disease

Indolinone derivatives

Method for lowering sorbitol levels using spiro-imides

Treating diabetes-associated complications with hydantoin amines

Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives

Aminophenyltetralin compounds

Aminophenyltetralin compounds

Imidazolidinedione derivatives in diabetes treatment

4-arylsulfonyl-3,4-dihydro-2(1H)-quinoxalinone-1-alkanoic acids, esters, and salts

[1,2,4]Triazolo[4,3-a]quinoxaline-4-amine derivatives

Intermediates for 1,3-disubstituted piperidine compounds as neuroleptic agents

1,3-disubstituted piperidine compounds as neuroleptic agents

Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents

Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents

Intermediates in the preparation of chiral hydantoins

Process for the preparation of chiral hydantoins

Hydantoin derivatives

Hydantoin derivatives as therapeutic agents

Benzimidazolone derivatives

Method of treating anxiety and depression with 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents

Indolinone derivatives

Spiro-polycyclicimidazolidinedione derivatives

Spiro-furanohydantoin derivatives

8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4&#39;-imidazolidine]-2&#39;,5&#39;-dione

6-Halo-4-chromanamines useful as intermediates to make chiral hydantoins

Hydantoin derivatives, anti-diabetic compositions thereof, and method of use thereof

Hydantoin derivatives as therapeutic agents

Tetrahydroquinoline hydantoins for chronic diabetic complications

Hydantoin therapeutic agents

Benzenesulfonylurea derivatives

1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents

1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents

Heteroylidene indolone compounds

Spiro-imide derivatives

Imide derivatives

Imidazolone derivatives

Aminoquinoline derivatives

Piperidinesulfonylurea derivatives

4-Substituted-1-piperidinesulfonamides

Composition comprising a benzenesulfonylurea hypoglycemic agent and method of treatment

Combination therapy for Parkinson's disease

8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione